The Infertility Prevention Project - a collaboration between Centers for Disease Control and Prevention (CDC) and Office of Population Affairs (OPA) - funds chlamydia screening and treatment services for low-income, sexually active women attending family planning, sexually transmitted disease (STD), and other public health clinics. The program is based on the premise that timely treatment for chlamydia and gonorrhea can reduce the debilitating complications caused by these STDs, including pelvic inflammatory disease (PID), ectopic pregnancy, and infertility.
Chlamydia infection is suspected to be the number one cause of preventable infertility. In the U.S. each year, as many as 3 million men and women contract chlamydia; it is the most common bacterial STD. Enormous cost is associated with chlamydia infections. Annually over $2 billion dollars are spent on the medical management of chlamydia and related complications such as PID. Screening of the highest risk population is the best way to catch the infection early before it leads to further sequelae since up to 80% of women & men show no visible signs or symptoms of infection. If identified early, chlamydia infections are easily and effectively treated with antibiotics.
Gonorrhea is less common than chlamydia, and screening is recommended in high risk areas and determined by individual project areas. Evidence suggests that comprehensive screening, treatment, partner notification, and education can significantly reduce the prevalence and sequelae of chlamydia and gonorrhea. The Region I Infertility Prevention Project plays an important role in the implementation of these efforts in the New England Region.
National Infertility Prevention Project
Region I Infertility Prevention Project
JSI Research and Training
From 1995-2012, JSI Research & Training Institute, Inc. successfully served as the coordinator of the Region I Infertility Prevention Project (IPP). Further information about the Region I Infertility Prevention Project can be obtained on JSI.com.